Atalaya Capital Management LP Alpha Tau Medical Ltd. Transaction History
Atalaya Capital Management LP
- $40.8 Million
- Q2 2024
A detailed history of Atalaya Capital Management LP transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Atalaya Capital Management LP holds 27,180 shares of DRTS stock, worth $83,714. This represents 0.17% of its overall portfolio holdings.
Number of Shares
27,180
Previous 73,742
63.14%
Holding current value
$83,714
Previous $217,000
68.66%
% of portfolio
0.17%
Previous 0.57%
Shares
2 transactions
Others Institutions Holding DRTS
# of Institutions
29Shares Held
1.36MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY307KShares$946,5610.07% of portfolio
-
Hoyle Cohen, LLC269KShares$828,7910.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$710,5680.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$204,2840.01% of portfolio
-
Satovsky Asset Management LLC53.6KShares$165,1060.03% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $213M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...